skip to Main Content

DNA Oestrogen

DNA Oestrogen tests for high-risk polymorphisms that have been shown to affect metabolism of oestrogen and related compounds. Cumulative exposure to oestrogen has been shown to have a high correlation to the development of breast cancer. The test is therefore particularly important for woman considering oral contraceptives, hormone replacement therapy, bio-identical supplementation, women who are considering in vitro fertilization or who have been diagnosed with estrogen receptor-positive breast cancer.

DNA Oestrogen reports on the following areas:

  • Polymorphisms in key genes involved in metabolizing oestrogen and related compounds
  • Impact of high-risk polymorphisms
  • Intervention strategies for carriers
  • Personal risk factors associated with HRT, Oral contraceptives, bio-identical supplementation
  • and in vitro fertilization